Professor Raymond Schinazi Joins Board Of reViral As Non-Executive Director

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LONDON, Apr 15, 2014 (PR Newswire Europe via COMTEX) -- LONDON, April 15, 2014 /PRNewswire/ --

reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news